ATE475424T1 - Cellulosesulfat zur behandlung von rhinovirus- infektionen - Google Patents

Cellulosesulfat zur behandlung von rhinovirus- infektionen

Info

Publication number
ATE475424T1
ATE475424T1 AT07723804T AT07723804T ATE475424T1 AT E475424 T1 ATE475424 T1 AT E475424T1 AT 07723804 T AT07723804 T AT 07723804T AT 07723804 T AT07723804 T AT 07723804T AT E475424 T1 ATE475424 T1 AT E475424T1
Authority
AT
Austria
Prior art keywords
treatment
cellulose sulfate
rhinovirus infections
rhinovirus
polymer
Prior art date
Application number
AT07723804T
Other languages
English (en)
Inventor
Andreas Grassauer
Alexander Pretsch
Original Assignee
Marinomed Biotechnologie Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP06450051A external-priority patent/EP1842545A1/de
Priority claimed from EP06450052A external-priority patent/EP1842546B1/de
Application filed by Marinomed Biotechnologie Gmbh filed Critical Marinomed Biotechnologie Gmbh
Application granted granted Critical
Publication of ATE475424T1 publication Critical patent/ATE475424T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Otolaryngology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
AT07723804T 2006-04-04 2007-03-30 Cellulosesulfat zur behandlung von rhinovirus- infektionen ATE475424T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06450051A EP1842545A1 (de) 2006-04-04 2006-04-04 Entzündungshemmende Polymer
EP06450052A EP1842546B1 (de) 2006-04-04 2006-04-04 Zellulosesulfat zur Behandlung von Rhinovirus-Infektionen
PCT/EP2007/002862 WO2007112966A1 (en) 2006-04-04 2007-03-30 Cellulose sulfate for the treatment of rhinovirus infection

Publications (1)

Publication Number Publication Date
ATE475424T1 true ATE475424T1 (de) 2010-08-15

Family

ID=38325129

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07723804T ATE475424T1 (de) 2006-04-04 2007-03-30 Cellulosesulfat zur behandlung von rhinovirus- infektionen

Country Status (5)

Country Link
US (2) US20100160254A1 (de)
EP (2) EP2040716B1 (de)
AT (1) ATE475424T1 (de)
DE (1) DE602007008100D1 (de)
WO (2) WO2007112966A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5702526B2 (ja) * 2009-04-30 2015-04-15 Ｅｓファイバービジョンズ株式会社 抗ウイルス性を有する硫酸化セルロースを担持させた繊維集合体
US20130028882A1 (en) 2011-07-07 2013-01-31 Humanitas Technology, LLC Antiviral compositions and methods of their use
WO2014147287A1 (en) 2013-03-21 2014-09-25 Jukka Seppälä Nanocrystalline cellulose (ncc) as an antiviral compound
US9480828B2 (en) * 2013-11-14 2016-11-01 Gyrus Acmi, Inc. Treatment method for the inferior turbinate
US12228578B2 (en) 2020-12-17 2025-02-18 Idexx Laboratories, Inc. Rocky mountain spotted fever detection and treatment
CN113999435B (zh) * 2021-11-09 2022-10-18 湖北省农业科学院农产品加工与核农技术研究所 一种响应面法优化的改性壳聚糖-lzm-ca复合抑菌保鲜膜及其制备方法和应用

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1327354C (en) * 1987-03-19 1994-03-01 David Cullis-Hill Anti-inflamatory compounds and compositions
US6514936B1 (en) * 1988-09-01 2003-02-04 Bayer Corporation Antiviral methods using human rhinovirus receptor (ICAM-1)
EP0468257B1 (de) * 1990-07-20 1999-09-01 Bayer Corporation Multimere Formen des menschlichen Rhinovirus-Rezeptorproteins
US6063773A (en) * 1995-09-29 2000-05-16 Polydex Pharmaceuticals Ltd. Cellulose sulfate for use as antimicrobial and contraceptive agent
SE9604610D0 (sv) * 1996-12-16 1996-12-16 Noviscens Ab Medical composition
US6391452B1 (en) * 1997-07-18 2002-05-21 Bayer Corporation Compositions for nasal drug delivery, methods of making same, and methods of removing residual solvent from pharmaceutical preparations
JP2000256196A (ja) * 1999-03-05 2000-09-19 Pias Arise Kk 抗炎症，抗アレルギー剤
KR100317482B1 (ko) 1999-09-10 2002-01-18 유향자 수용성 키토산을 함유한 김치 영양강화제 및 이의 사용방법
US20030077301A1 (en) * 1999-12-16 2003-04-24 Maibach Howard I. Topical pharmaceutical composition for the treatment of inflammatory dermatoses
US6492350B2 (en) * 2000-01-27 2002-12-10 Jdc (Hawaii) Inc. Chitin oligosaccharides and/or chitosan oligosaccharides for preventing or treating common cold or treating pain
EP1127574A1 (de) * 2000-02-22 2001-08-29 Food Industry Research and Development Institute Verwendung von Chitin-enthaltenden Produkten zur Hemmung von der Erzeugung von NO
DK1296691T3 (da) * 2000-06-30 2006-03-20 Univ Rush Medical Center Anvendelse af cellulosesulfat og andre sulfaterede polysaccharider til forebyggelse og behandling af papillomvirusinfektioner
KR100413215B1 (ko) * 2001-02-08 2003-12-31 주식회사 자광 수용성 키토산과 목향추출물로 구성된 천연 셀 전달체
US20030181416A1 (en) * 2002-01-10 2003-09-25 Comper Wayne D. Antimicrobial charged polymers that exhibit resistance to lysosomal degradation during kidney filtration and renal passage, compositions and method of use thereof
JP2004196748A (ja) * 2002-12-20 2004-07-15 Daiwa:Kk キトサン含有消炎鎮痛皮膚外用液剤
WO2004085486A1 (ja) * 2003-03-25 2004-10-07 Sekisui Chemical Co., Ltd. 皮膚外用組成物
US20050009782A1 (en) * 2003-07-09 2005-01-13 Comper Wayne D. Antiviral charged polymers that exhibit resistance to lysosomal degradation during kidney filtration and renal passage, compositions and methods of use thereof
JP2005029525A (ja) * 2003-07-09 2005-02-03 Harasawa Pharmaceutical Co Ltd シリコーンを主成分とする皮膚外用剤
US7968122B2 (en) * 2003-12-10 2011-06-28 Adventrx Pharmaceuticals, Inc. Anti-viral pharmaceutical compositions
US20060040896A1 (en) * 2004-08-18 2006-02-23 Paringenix, Inc. Method and medicament for anticoagulation using a sulfated polysaccharide with enhanced anti-inflammatory activity

Also Published As

Publication number Publication date
EP2007401A2 (de) 2008-12-31
US20100160254A1 (en) 2010-06-24
WO2007112966A1 (en) 2007-10-11
WO2007112968A2 (en) 2007-10-11
EP2040716A1 (de) 2009-04-01
DE602007008100D1 (de) 2010-09-09
WO2007112968A3 (en) 2007-11-15
EP2040716B1 (de) 2010-07-28
US20090298792A1 (en) 2009-12-03

Similar Documents

Publication Publication Date Title
DE602007005697D1 (de) Verwendung von carrageenan zur behandlung von rhinovirus-infektionen
EA200802213A1 (ru) Способы лечения заболеваний крови
DK1853602T3 (da) Kemiske forbindelser
CY1108275T1 (el) Χημικες ενωσεις
CY1111454T1 (el) Παραγωγα φαινυλο-πυραζολιου ως συνδετες υποδοχεα μη στεροειδων γλυκοκορτικοειδων
EA200801997A1 (ru) Новые соединения
ECSP077360A (es) Compuestos sulfonamida
HRP20110861T1 (hr) Lijek za liječenje gripe
EA201000329A1 (ru) Циклические депсипептиды
CL2007002346A1 (es) Compuestos no nucleosidicos derivados de fenoxi-fenil sustituidos, inhibidores de la transcriptasa inversa del vih; composicion farmaceutica; y su uso para tratar prevenir una infeccion vih o para tratar el sida o crs.
EA200802111A1 (ru) Имплантаты для лечения состояний, ассоциируемых с допамином
ATE475424T1 (de) Cellulosesulfat zur behandlung von rhinovirus- infektionen
MA32841B1 (fr) Composés de cycloundeca depsipeptides et leur utilisation comme médicament
CY1114760T1 (el) Θεραπευτικη αγωγη αθηροσκληρωσης
EA200702336A1 (ru) ПРИМЕНЕНИЕ 24-норУДХК
UA94781C2 (ru) Применение йота-каррагенана для профилактики или терапевтического лечения риновирусной инфекции
ATE501717T1 (de) Einsatz von agomelatin zur herstellung von medikamenten zur behandlung des smith-magenis- syndroms (sms)
CY1112443T1 (el) Νεα θεραπευτικη χρηση για τη θεραπεια των λευχαιμιων
ATE424834T1 (de) Zellulosesulfat zur behandlung von rhinovirus- infektionen
EA200800151A1 (ru) Производные хинолина в качестве антибактериальных агентов
FR2905600B1 (fr) Traitement des vertiges par l'acetyl-l-leucine.
EA200870263A1 (ru) Внутривенный способ лечения вирусной инфекции
ATE456949T1 (de) Verwendung von bupropionmetaboliten zur behandlung von entzündungserkrankungen
RU2007145646A (ru) Средство для лечения вич-инфекции
EP1945223A4 (de) Cefquinomzusammensetzungen und verfahren zu ihrer verwendung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties